Skip to main content
. 2016 Nov 25;8(1):1141–1155. doi: 10.18632/oncotarget.13588

Table 2. Characteristics of included patients.

ACT-group (%) N=956 (100%) CT-group (%) N=942 (100%)
Sex
Male 534 (56%) 539 (57%)
Female 349 (36%) 327 (35%)
unknown 73 (8%) 76 (8%)
ECOG PS
0 138 (14%) 177 (19%)
1 416 (44%) 385 (41%)
2 121 (13%) 78 (8%)
3 13 (1%) 29 (3%)
unknown 268 (28%) 273 (29%)
Stage
Extensive 556 (58%) 519 (55%)
Limited 280 (29%) 295 (31%)
unknown 120 (13%) 128 (14%)